Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein beta.
CCAAT/enhancer-binding Protein beta (C/EBPbeta) is a member of the bZIP transcription factor family that is expressed in various tissues, including cells of the hematopoietic system. C/EBPbeta is involved in tissue-specific gene expression and thereby takes part in fundamental cellular processes such as proliferation and differentiation. Here, we show that the activity of C/EBPbeta is negatively regulated by the transcriptional co-repressor Daxx. C/EBPbeta was found to directly interact with Daxx after overexpression as well as on the endogenous level. Glutathione S-transferase pulldown assays showed that Daxx binds via amino acids 190-400 to the C-terminal part of C/EBPbeta. Co-expression of C/EBPbeta changed the sub-nuclear Daxx distribution pattern from predominantly POD-localized to nucleoplasmic. Daxx suppressed basal and p300-enhanced transcriptional activity of C/EBPbeta. Furthermore, Daxx decreased the C/EBPbeta-dependent phosphorylation of p300, which in turn was associated with a diminished level of p300-mediated C/EBPbeta acetylation. Co-expression of promyelocytic leukemia protein abrogated the repressive effect of Daxx on C/EBPbeta as well as the direct interaction of Daxx and C/EBPbeta, presumably by re-recruiting Daxx to PML-oncogenic domains. In acute promyelocytic leukemia (APL) cells, C/EBPbeta activity is known to be required for all-trans-retinoic acid-induced cell differentiation and disease remission. We show that all-trans-retinoic acid as well as arsenic trioxide treatment leads to a reduced C/EBPbeta fraction associated with Daxx suggesting a relief of Daxx-dependent C/EBPbeta repression as an important molecular event leading to APL cell differentiation. Overall, our data identify Daxx as a new negative regulator of C/EBPbeta and provide first clues for a link between abrogation of Daxx-C/EBPbeta complex formation and APL remission.
Wethkamp
Nils
N
Institut für Biochemie, Westfälische-Wilhelms-Universität Münster, Wilhelm-Klemm-Strasse 2, Münster D-48149, Germany.
Klempnauer
Karl-Heinz
KH
D048868:Adaptor Proteins, Signal Transducing; D000818:Animals; D022782:CCAAT-Enhancer-Binding Protein-beta / Q000378:metabolism*; D002454:Cell Differentiation; D056970:Co-Repressor Proteins; D005347:Fibroblasts / Q000378:metabolism; D005786:Gene Expression Regulation; D015973:Gene Expression Regulation, Leukemic; D006367:HeLa Cells; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000378:metabolism; D018832:Molecular Chaperones; D009687:Nuclear Proteins; D010766:Phosphorylation; D017434:Protein Structure, Tertiary; D011784:Quail; D014212:Tretinoin / Q000378:metabolism; D050880:p300-CBP Transcription Factors / Q000378:metabolism
D048868:Adaptor Proteins, Signal Transducing; D022782:CCAAT-Enhancer-Binding Protein-beta; D056970:Co-Repressor Proteins; C106985:DAXX protein, human; D018832:Molecular Chaperones; D009687:Nuclear Proteins; D014212:Tretinoin; D050880:p300-CBP Transcription Factors
Mol Cell Biol. 1997 Nov;17(11):6609-17
9343424
EMBO J. 2003 Nov 3;22(21):5806-16
14592978
Br J Haematol. 2001 Nov;115(2):287-97
11703323
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2703-8
17301242
J Biol Chem. 2002 Jul 12;277(28):25446-56
11948183
Genes Dev. 1994 Nov 15;8(22):2781-91
7958933
Nat Cell Biol. 2008 May;10(5):547-55
18408733
J Biol Chem. 2004 Nov 12;279(46):48013-23
15339933
Cell. 1993 Aug 13;74(3):423-31
8394219
Genes Dev. 1999 Aug 1;13(15):1918-23
10444590
J Biol Chem. 2003 May 2;278(18):15958-65
12595526
Nat Cell Biol. 2001 Aug;3(8):708-14
11483955
J Exp Med. 2000 Feb 21;191(4):631-40
10684855
EMBO J. 1996 Jun 3;15(11):2771-80
8654374
J Biol Chem. 2002 Mar 29;277(13):11156-64
11799127
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):207-12
11756662
Oncogene. 2008 Apr 3;27(15):2177-86
17952115
J Biol Chem. 2002 Nov 15;277(46):44557-65
12213825
Cell. 1994 Jan 28;76(2):333-43
8293467
Cell. 1994 Jan 28;76(2):345-56
8293468
Genes Dev. 2008 Apr 15;22(8):998-1010
18413714
Biochem Soc Trans. 2007 Dec;35(Pt 6):1397-400
18031230
Nucleic Acids Res. 2003 Sep 15;31(18):5356-67
12954772
Mol Cell Biol. 2008 Mar;28(6):2102-12
18195047
Cell. 1997 Jun 27;89(7):1067-76
9215629
J Biol Chem. 2003 Mar 14;278(11):9609-19
12524424
Oncogene. 2000 Feb 10;19(6):745-53
10698492
Cancer Res. 2003 Dec 1;63(23):8271-7
14678985
Cancer Cell. 2005 Feb;7(2):143-53
15710327
Mol Cell. 2006 Nov 3;24(3):341-54
17081986
Mol Cell Biol. 2004 Dec;24(24):10529-41
15572661
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10635-40
12953102
Mol Cell Biol. 2000 Mar;20(5):1784-96
10669754
EMBO J. 2006 Sep 6;25(17):3955-65
16917507
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4100-5
15016915
Br J Cancer. 1999 Mar;79(7-8):1240-8
10098766
Mol Cell Biol. 2005 Jan;25(1):499-511
15601869
EMBO J. 1999 Jul 1;18(13):3702-11
10393185
J Biol Chem. 2003 Aug 29;278(35):33416-21
12810706
J Biol Chem. 2005 Mar 18;280(11):10164-73
15637079
J Immunol. 2006 Apr 15;176(8):4843-51
16585579
Mol Cell Biol. 2003 Oct;23(20):7108-21
14517282
Oncogene. 2001 Jan 4;20(1):1-9
11244500
J Biol Chem. 2007 Jan 12;282(2):956-67
17110376
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):16973-8
16287980
J Cell Biol. 1999 Oct 18;147(2):221-34
10525530
Curr Opin Cell Biol. 2008 Apr;20(2):180-5
18358708
Cell. 1991 Aug 23;66(4):663-74
1652368
Nature. 1998 Feb 19;391(6669):811-4
9486654
Blood Rev. 2003 Jun;17(2):71-97
12642121
J Biol Chem. 2008 Sep 26;283(39):26357-63
18647749
Genes Dev. 2000 Aug 1;14(15):1920-32
10921906
Nat Cell Biol. 2008 May;10(5):538-46
18408734
EMBO J. 2003 Feb 17;22(4):882-92
12574124
J Cell Sci. 2002 Aug 15;115(Pt 16):3319-30
12140263
J Mol Biol. 2007 Apr 27;368(2):388-97
17362989
EMBO J. 1994 Mar 1;13(5):1073-83
8131741
J Biol Chem. 2003 Sep 19;278(38):36959-65
12857754
Mol Cell Endocrinol. 2008 Jul 16;289(1-2):94-101
18486321
J Biol Chem. 2001 Oct 19;276(42):39103-6
11495919
Nature. 1990 Oct 11;347(6293):558-61
2170850